Thank you.
You alluded to this. The original cause of the opioid crisis was Purdue Pharma. They advanced drug liberalization in order to aggressively market their own new opioid product, OxyContin, in the 1990s and early 2000s. This is how the first opioid crisis began, and certainly there was conflict of interest rampant at that time with people moving back and forth between companies and regulators, etc.
Today, Purdue is at it again. Their own branded hydromorphone product, Dilaudid, seems to be the preferred option for this program of state-subsidized hard drug distribution.
It seems bizarre to me that the people responsible for the opioid crisis at Purdue are now making even more money selling drugs, marketing easier access and drug liberalization as a solution to the problem.
Do you have any insight into why a Purdue product specifically has become the go-to and what Purdue has done to engage government and civil society to be able to bring about this outcome that's very financially beneficial to them?